| UniProt ID | STON2_HUMAN | |
|---|---|---|
| UniProt AC | Q8WXE9 | |
| Protein Name | Stonin-2 | |
| Gene Name | STON2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 905 | |
| Subcellular Localization | Cytoplasm . Membrane . Cell junction, synapse, synaptosome. Some fraction is membrane-associated. | |
| Protein Description | Adapter protein involved in endocytic machinery. Involved in the synaptic vesicle recycling. May facilitate clathrin-coated vesicle uncoating.. | |
| Protein Sequence | MTTLDHVIATHQSEWVSFNEEPPFPAHSQGGTEEHLPGLSSSPDQSESSSGENHVVDGGSQDHSHSEQDDSSEKMGLISEAASPPGSPEQPPPDLASAISNWVQFEDDTPWASTSPPHQETAETALPLTMPCWTCPSFDSLGRCPLTSESSWTTHSEDTSSPSFGCSYTDLQLINAEEQTSGQASGADSTDNSSSLQEDEEVEMEAISWQASSPAMNGHPAPPVTSARFPSWVTFDDNEVSCPLPPVTSPLKPNTPPSASVIPDVPYNSMGSFKKRDRPKSTLMNFSKVQKLDISSLNRTPSVTEASPWRATNPFLNETLQDVQPSPINPFSAFFEEQERRSQNSSISSTTGKSQRDSLIVIYQDAISFDDSSKTQSHSDAVEKLKQLQIDDPDHFGSATLPDDDPVAWIELDAHPPGSARSQPRDGWPMMLRIPEKKNIMSSRHWGPIFVKLTDTGYLQLYYEQGLEKPFREFKLEICHEISEPRLQNYDENGRIHSLRIDRVTYKEKKKYQPKPAVAHTAEREQVIKLGTTNYDDFLSFIHAVQDRLMDLPVLSMDLSTVGLNYLEEEITVDVRDEFSGIVSKGDNQILQHHVLTRIHILSFLSGLAECRLGLNDILVKGNEIVLRQDIMPTTTTKWIKLHECRFHGCVDEDVFHNSRVILFNPLDACRFELMRFRTVFAEKTLPFTLRTATSVNGAEVEVQSWLRMSTGFSANRDPLTQVPCENVMIRYPVPSEWVKNFRRESVLGEKSLKAKVNRGASFGSTSVSGSEPVMRVTLGTAKYEHAFNSIVWRINRLPDKNSASGHPHCFFCHLELGSDREVPSRFANHVNVEFSMPTTSASKASVRSISVEDKTDVRKWVNYSAHYSYQVALGSIWLMLPTPFVHPTTLPLLFLLAMLTMFAW | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 168 | Phosphorylation | SPSFGCSYTDLQLIN CCCCCCCHHEEEEEC | 14.35 | 22817900 | |
| 231 | Phosphorylation | VTSARFPSWVTFDDN CCCCCCCCCEEECCC | 31.31 | - | |
| 234 | Phosphorylation | ARFPSWVTFDDNEVS CCCCCCEEECCCEEC | 18.32 | - | |
| 241 | Phosphorylation | TFDDNEVSCPLPPVT EECCCEECCCCCCCC | 12.11 | 27251275 | |
| 248 | Phosphorylation | SCPLPPVTSPLKPNT CCCCCCCCCCCCCCC | 30.33 | 27251275 | |
| 249 | Phosphorylation | CPLPPVTSPLKPNTP CCCCCCCCCCCCCCC | 28.59 | 24719451 | |
| 255 | Phosphorylation | TSPLKPNTPPSASVI CCCCCCCCCCCCCCC | 45.14 | 27251275 | |
| 267 | Phosphorylation | SVIPDVPYNSMGSFK CCCCCCCCCCCCCCC | 21.51 | 25627689 | |
| 269 | Phosphorylation | IPDVPYNSMGSFKKR CCCCCCCCCCCCCCC | 20.76 | 25627689 | |
| 272 | Phosphorylation | VPYNSMGSFKKRDRP CCCCCCCCCCCCCCC | 25.83 | 25159151 | |
| 281 | Phosphorylation | KKRDRPKSTLMNFSK CCCCCCCCCCCCHHH | 29.47 | 30266825 | |
| 282 | Phosphorylation | KRDRPKSTLMNFSKV CCCCCCCCCCCHHHC | 35.83 | 30266825 | |
| 287 | Phosphorylation | KSTLMNFSKVQKLDI CCCCCCHHHCEECCH | 27.23 | 30266825 | |
| 295 | Phosphorylation | KVQKLDISSLNRTPS HCEECCHHHCCCCCC | 28.56 | 30266825 | |
| 296 | Phosphorylation | VQKLDISSLNRTPSV CEECCHHHCCCCCCC | 29.96 | 25849741 | |
| 300 | Phosphorylation | DISSLNRTPSVTEAS CHHHCCCCCCCCCCC | 20.88 | 25159151 | |
| 302 | Phosphorylation | SSLNRTPSVTEASPW HHCCCCCCCCCCCCC | 40.85 | 25159151 | |
| 304 | Phosphorylation | LNRTPSVTEASPWRA CCCCCCCCCCCCCCC | 30.12 | 23186163 | |
| 307 | Phosphorylation | TPSVTEASPWRATNP CCCCCCCCCCCCCCC | 20.82 | 25159151 | |
| 319 | Phosphorylation | TNPFLNETLQDVQPS CCCCCCCCCCCCCCC | 28.75 | 27251275 | |
| 326 | Phosphorylation | TLQDVQPSPINPFSA CCCCCCCCCCCCCHH | 22.71 | 25159151 | |
| 342 | Phosphorylation | FEEQERRSQNSSISS HHHHHHHHCCCCCCC | 39.68 | 25627689 | |
| 345 | Phosphorylation | QERRSQNSSISSTTG HHHHHCCCCCCCCCC | 22.78 | 25262027 | |
| 346 | Phosphorylation | ERRSQNSSISSTTGK HHHHCCCCCCCCCCC | 33.76 | 25262027 | |
| 348 | Phosphorylation | RSQNSSISSTTGKSQ HHCCCCCCCCCCCCH | 24.47 | 25262027 | |
| 349 | Phosphorylation | SQNSSISSTTGKSQR HCCCCCCCCCCCCHH | 28.46 | 25262027 | |
| 350 | Phosphorylation | QNSSISSTTGKSQRD CCCCCCCCCCCCHHC | 32.55 | 25262027 | |
| 351 | Phosphorylation | NSSISSTTGKSQRDS CCCCCCCCCCCHHCE | 44.56 | 25262027 | |
| 353 | Ubiquitination | SISSTTGKSQRDSLI CCCCCCCCCHHCEEE | 41.12 | - | |
| 354 | Phosphorylation | ISSTTGKSQRDSLIV CCCCCCCCHHCEEEE | 31.62 | 28857561 | |
| 358 | Phosphorylation | TGKSQRDSLIVIYQD CCCCHHCEEEEEEEE | 23.37 | 28857561 | |
| 363 | Phosphorylation | RDSLIVIYQDAISFD HCEEEEEEEEECCCC | 6.88 | 28060719 | |
| 368 | Phosphorylation | VIYQDAISFDDSSKT EEEEEECCCCCCCCC | 25.09 | 28060719 | |
| 384 | Ubiquitination | SHSDAVEKLKQLQID CCHHHHHHHHHCCCC | 55.15 | 2190698 | |
| 384 (in isoform 1) | Ubiquitination | - | 55.15 | 21906983 | |
| 386 | Ubiquitination | SDAVEKLKQLQIDDP HHHHHHHHHCCCCCC | 61.09 | - | |
| 437 | Acetylation | MMLRIPEKKNIMSSR EEEECCCCCCCCCCC | 45.85 | 18604539 | |
| 498 | Phosphorylation | DENGRIHSLRIDRVT CCCCCEEEEEEEEEE | 19.57 | 24719451 | |
| 512 | Phosphorylation | TYKEKKKYQPKPAVA EHHCCCCCCCCCCCC | 38.64 | 22210691 | |
| 515 | Ubiquitination | EKKKYQPKPAVAHTA CCCCCCCCCCCCCHH | 30.04 | - | |
| 580 | Phosphorylation | VDVRDEFSGIVSKGD EEEHHHHCCEEECCC | 26.09 | 22617229 | |
| 621 | Ubiquitination | GLNDILVKGNEIVLR CCCCEEEECCEEEEC | 53.20 | - | |
| 638 | Ubiquitination | IMPTTTTKWIKLHEC CCCCCCCCEEEEEEC | 44.84 | - | |
| 684 | Ubiquitination | FRTVFAEKTLPFTLR HHHEECCCCCCEEEE | 52.51 | - | |
| 684 | Acetylation | FRTVFAEKTLPFTLR HHHEECCCCCCEEEE | 52.51 | 26051181 | |
| 689 | Phosphorylation | AEKTLPFTLRTATSV CCCCCCEEEEECCCC | 17.25 | 24719451 | |
| 746 | Phosphorylation | VKNFRRESVLGEKSL HHHCHHHHHCCCHHH | 22.34 | 23312004 | |
| 751 | Ubiquitination | RESVLGEKSLKAKVN HHHHCCCHHHHHHCC | 60.33 | - | |
| 762 | Phosphorylation | AKVNRGASFGSTSVS HHCCCCCCCCCCCCC | 32.72 | 25159151 | |
| 765 | Phosphorylation | NRGASFGSTSVSGSE CCCCCCCCCCCCCCC | 18.59 | 28857561 | |
| 766 | Phosphorylation | RGASFGSTSVSGSEP CCCCCCCCCCCCCCC | 33.26 | 28857561 | |
| 767 | Phosphorylation | GASFGSTSVSGSEPV CCCCCCCCCCCCCCE | 18.91 | 28857561 | |
| 769 | Phosphorylation | SFGSTSVSGSEPVMR CCCCCCCCCCCCEEE | 36.05 | 26434776 | |
| 771 | Phosphorylation | GSTSVSGSEPVMRVT CCCCCCCCCCEEEEE | 31.08 | 26434776 | |
| 856 | Phosphorylation | SISVEDKTDVRKWVN EEECCCCCCHHHHHH | 52.64 | - | |
| 914 (in isoform 3) | Phosphorylation | - | 27251275 | ||
| 915 (in isoform 3) | Phosphorylation | - | 27251275 | ||
| 918 (in isoform 3) | Phosphorylation | - | 27251275 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of STON2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of STON2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of STON2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| EP15R_HUMAN | EPS15L1 | physical | 11381094 | |
| EPS15_HUMAN | EPS15 | physical | 11381094 | |
| ITSN1_HUMAN | ITSN1 | physical | 11381094 | |
| SYT2_HUMAN | SYT2 | physical | 11381094 | |
| SYT1_HUMAN | SYT1 | physical | 11381094 | |
| SYT1_HUMAN | SYT1 | physical | 11454741 | |
| AP2M1_HUMAN | AP2M1 | physical | 11454741 | |
| CSN4_HUMAN | COPS4 | physical | 21102408 | |
| EPS15_HUMAN | EPS15 | physical | 18200045 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-300 AND SER-302, ANDMASS SPECTROMETRY. | |